Shandong Xinhua Pharmaceutical (SHE:000756) obtained drug registration from China's medical products regulator for its bisoprolol fumarate tablets.
The drug is indicated for treating hypertension, angina and chronic heart failure, according to Tuesday filing with the Shenzhen bourse.
Shres of the pharmaceutical company rose 2% in recent trade.